NCT04019821View on ClinicalTrials.gov

Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

January 1, 2023

Study Completion Date

April 1, 2023

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Insulin Glulisine

A type of bolus insulin will be insulin glulisine if participant used insulin glulisine before entering the trial.

DRUG

Insulin Aspart

A type of bolus insulin will be insulin aspart if participant used insulin aspart before entering the trial.

DRUG

Insulin Lispro

A type of bolus insulin will be insulin lispro if participant used insulin lispro before entering the trial.

Trial Locations (1)

Unknown

Department of Pediatric Diabetology and Pediatrics, Pediatric Teaching Clinical Hospital, Warsaw

All Listed Sponsors
lead

Medical University of Warsaw

OTHER

NCT04019821 - Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal | Biotech Hunter | Biotech Hunter